CD39 Antibodies

De Giorgi, Enjyoji, Jiang, Csizmadia, Mitsuhashi, Gumina, Smolenski, Robson: "Complete deletion of Cd39 is atheroprotective in apolipoprotein E-deficient mice." in: Journal of lipid research, Vol. 58, Issue 7, pp. 1292-1305, (2018) (PubMed).

Kaniewska-Bednarczuk, Kutryb-Zajac, Sarathchandra, Pelikant-Malecka, Sielicka, Piotrowska, Slominska, Chester, Yacoub, Smolenski: "CD39 and CD73 in the aortic valve-biochemical and immunohistochemical analysis in valve cell populations and its changes in valve mineralization." in: Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology, Vol. 36, pp. 53-63, (2018) (PubMed).

Boudreaux, Koehler, Habecker, Del Piero: "Evaluation of the genes encoding CD39/NTPDase-1 and CD39L1/NTPDase-2 in horses with and without abnormal hemorrhage and in horses with pathologic evidence of exercise-induced pulmonary hemorrhage." in: Veterinary clinical pathology, Vol. 44, Issue 4, pp. 617-25, (2016) (PubMed).

Smith, Xu, Novitskaya, Zhang, Chepurko, Pu, Wheeler, Ziolo, Gumina: "Impact of cardiac-specific expression of CD39 on myocardial infarct size in mice." in: Life sciences, (2016) (PubMed).

Hayes, Cairns, Levashova, Chinn, Perez, Theunissen, Liao-Chan, Bermudez, Flory, Schweighofer, H van der Horst: "CD39 is a promising therapeutic antibody target for the treatment of soft tissue sarcoma." in: American journal of translational research, Vol. 7, Issue 6, pp. 1181-8, (2015) (PubMed).

Cinti, De Giorgi, Chisci, Arena, Galimberti, Farina, Bugarin, Rivolta, Gaipa, Smolenski, Cerrito, Lavitrano, Giovannoni: "Simultaneous Overexpression of Functional Human HO-1, E5NT and ENTPD1 Protects Murine Fibroblasts against TNF-α-Induced Injury In Vitro." in: PLoS ONE, Vol. 10, Issue 10, pp. e0141933, (2015) (PubMed).

Yu, Robson, Hill: "Expression and distribution of ectonucleotidases in mouse urinary bladder." in: PLoS ONE, Vol. 6, Issue 4, pp. e18704, (2011) (PubMed).

Dwyer, Deaglio, Gao, Friedman, Strom, Robson: "CD39 and control of cellular immune responses." in: Purinergic signalling, Vol. 3, Issue 1-2, pp. 171-80, (2008) (PubMed).

Yaccoby, Johnson, Mahaffey, Wezeman, Barlogie, Epstein: "Antimyeloma efficacy of thalidomide in the SCID-hu model." in: Blood, Vol. 100, Issue 12, pp. 4162-8, (2002) (PubMed).

Peng, Moffett, Myers, Fang, Stachowiak, Maher, Kratz, Hines, Fluharty, Mizukoshi, Bloom, Stachowiak: "Novel nuclear signaling pathway mediates activation of fibroblast growth factor-2 gene by type 1 and type 2 angiotensin II receptors." in: Molecular biology of the cell, Vol. 12, Issue 2, pp. 449-62, (2001) (PubMed).